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D91757 Prognostic Value of Dobutamine Echocardiographyin Patients With Coronary Artery Disease And
Severe Left Ventricular Dysfunction
U. Klaar,H.Baumgartner,M. Wutte,S. Khan,M. DeRobertis,Y. Kong-Lsu,
R. Siegel,G. Laufar, G. Maurer. Dews. of Cardiology arrd Sugey, Univ of
Vienna,Austria, Cedars-Sinai Medical Cente6 Los Angeles. CA, USA
The prognosticvalue of dobutamineecho on sunfivalin pts with coronary
arterydiseaseandsevere leftventriculardysfunctionisstillunknown.There-
fore, we studiedthe outcome (mean F/U 2.9 + 1.3 yrs) of 61 pts (M/F
50/11, age 80.5 + 10.1 yrs, EF 23.3 + 10.3%) who underwantdobutamina
echo. A 16-segmentmodel was used for semiquantitativeassessmentof
wallmotionat restandafteradministrationof5, 10,20, 30, and40 wg/kg/min
dobutamine.Segmentswere definedas viablewhenpresentingwithnormal
wall motionat restor when rest asynergyimprovedby at least one grade
with dobutamkre.CMthe 61 pts, 28 ultimatelyunderwentbypasssurgery.
6 of these died duringF/U whereas 22 were still alive. 13 pts underwent
hearttransplantation(HTX). Of the 20 pts withoutsurgicaltreatment13 pts
were stillalive whereas 7 pts died. CABG survivorshad significantlymore
viablesegmentsbydobutamineecho.Therewasonlya trendtowardshigher
EF but no statisticallysignificantdifferenceoomparedto ptswho died after
CABG. In contrast,in the non-CABGgroup,EF predictedsurvival,whereas
nosignificantdifferencewas foundby dobutamineecho.
CABG NoCABG
Alive Dead Alive DeadorHTX
N 22 6 13 20
# ViableSeg, 12.6&2.7 9.7+2.8’ 9.5k 2.8 9,4+ 3.9




CABG and may offer prognostic information above and beyond ejection
fraction.
D91770 Dobutamine-AtroPine Strese Echocardiography iaAccurate for Predicting the Extent of Coronary
Artery Disease
S. Smart,P.Dionisopoulos,K. Sagar. The Medical College of Wisconein,
Milwaukee, WI. USA
Dobutamina-atropinastress echocardiography(DSE) has been shownto
accuratelydetect the presence of coronaryartery diseaee (CAD), but its
accuracy for predictingthe extent of disease ie unknown.To determine
accuracyfor extent of CAD, 288 patiente(age 61 + 11 yearn, 187 men)
underwentDSE and coronaryangiographywithin2 montheof each other.
Atropinewas used in 145 patients. Peak haarl rate was 128 i.l7-bprn:-
DSE waa normal in 98 patients.Wall motionabnormalities(WMA) ware
detectedin 1 vascularterritory(1 VT) in 98 patients,2 VT in 58, and all 3
VT in 34. Angiographyrevealedno CAD (<50% Iuminaldiameteretenosis)
in 79 patients,singlevessel (IV) CAD in 67, 2V CAD in 77, and 3V CAD in
45. The saneitivityand specificityof multipleWMA for 2V or 3V CAD were
70% (185/122) and 98% (159/186), reepactively.Correlationof DSE and
angiographywas:
bVMAbyDSE
CADbyAnglo: 3vr 2VT lVT o Total
3V 16 16 7 4 45
2V 15 36 19 7 77
lV 3 4 63 17 S7
o 0 0 9 70 79
Total 34 56 96 98 288
ThenumbarofWMAcorrelatedwell(Pearson’sR= O.710,p < O.00000001)
withtha extentof angiographicCAD. MultipleWMA are sensitiveand very
specificfor multivesselCAD. In conclusion,the numberof WMA by DSE
accuratelypredictedthe extentof CAD by angiography.
D91771 Predictive Vaiue of Dobutamine StressEchocardiography Performed During g3-Blockada
T. Xie, M. Kumar,M. Khan,M. Adams,J. Esquivel-Avila,M. Ahmad.
University of TexasMedical Branch, Galveston, TX, USA
Three hundredand sixiy patients(pts) either on &Blocker therapy or on
no cardiacmedication duringDobutaminestressechocardiography(DSE)
wereaeleotedoutof 1322 consecutiveDSE studiesperformedfromJanuary
1992throughDecember1995 andwerefollowedforoardiaceventsincluding
unstableangina,myocardialinfarction,congestiveheartfailure,arrhythmia,
revascularlzation,and cardiacdeath, Eighty-ninepts(mean age+ SD, 55 +
10 yrs)on B-Blockers(Group1)were followedfor 18 + 10 monthsand 271
pts (53 + 12 yrs) withoutcardiacmedicationsduringDSE (Group 11)were
followedfor 17 + 9 months.Peak DSE heart rate, baseline/peakDSE LV
ejectionfraction(Mean + SD) were 111.6+ 25,2, 51.6 + 8.6/63.7 + 9.9 in
Group I compared to 131.2 + 19.2, 56.2 + 7.1/70.3 + 8.2 in Group II (p <
0.0001). The useofatropinewas notsignificantlydifferentinthe twogroups.
The sensitivitylevelsfor DSE in detectingischemiain GroupsI and II were
81% and 69%, respectively.Fifteenof 89 patients(16.9%) in Group I had
cardiaceventscomparedto 27 of271 pts(9.9%) inGroupIl. Positivepredic-
tive valuesof DSE were 21% in GroupI and 37% in GroupIl. Slx of 47 pts
withnegativaDSE in GroupI hadcardiaceventscomparedto 12 of 230 pts
in GroupII resultingin negativepredictivevaluesof 87°Aand 95%, respec-
tively(p < 0.05). The data indicatethat inp-Blockedpts, DSE is sensitivein
detectingIschemlahowever,Its negativepredictivevalue for futurecardiac
eventsisdecreasedwhencomparedto ptswithoutcardiacmedications.
/917-72/ E~oximonaE~ho~ardiograPhYfor,den*ifi~ationof
Viable Myocardium in Patients With Iachaemic
Ventricular Dysfunction: Comparison With
Dobutemine Echocardiography and Poeitron
Emission Tomography
M. Carlino,S. Chierchia,C. Lu,A. Margonato,R. Poletd,C. Landoni,
G. Lucignani./RCCS H.San. Raffae/e, Milan, /tafy
Enoximone,a nongiycoeide,noncstecholpositiveinotropicagent has been
proposedin combinationwithtwo-dimensionalechocardiographyas a new
toolto identifymyocardialviability.We studied10 patientswithpreviouamy-
ocerdialinfarction(infarctage, >3 months)and depresaedleft ventricular
function(EF s 40%) by lowdose (5 to 10 &g/kgper rein)dobutamineecho-
cardiography(DE) and enoximone(1 mg/kgintravenously,over 5 minutes)
echocardiography(EE) ontwoconsecutivedays.Myocardialuptakeof F-18
fluorodeoxyglucose(FDG) was assessedby positronemissiontomography
(PET) afterprolonged(> 12 hra)fastingwithin5 daysofthe eohostudy.The
myocardiumwasdefinedasviablewhenthe FDG uptakewas abovethe95%
confidenceintervalassessedinfive normaisubjects.Digitizedecho images
at restand at peakof DE and EE were comparedqualitativelyon a cine-ioop
display,Syatolicfunctionwaa scoredfrom 1 (normal)to 4 (dyskinesia),and
functionalimprovementwas definedas a scorechange >1 grade. Of 126
dysfunctionaleegmente,51 (40%) were viable by PET criteria.Contractile
functionimprovedduringDE and EE, respectively,in 39 and 36 of theee
segmanta.(Sensitivity:DE = 76% ve EE = 71%, p = ns). Conversely,of
75 segmentswithoutPET viability,respectively,69 and 70 did not respond
(specificity:DE= 92% .s EE = 93%, p = ne)to the DE and EE. CoocorCfant
interpretationofEE andDEwasfoundin91% (115/126)ofaffectedsagments
(43 via6Te-and72 nonviable).EE didnotcauseany sideeffectand significant
changeeof heartrate (HR) and eystolicbloodpressure(BPs). In contrastto
EE, DE causedchestpain(n= 2), ischemia(n =2) and ventriculararrhyth-
mia (n= 4) and increaeedHR (by20%) and BP (by 15%). Conclusion: EE ie
an effectivenewteetthatdetecteresidualviabilitywitheeneitivitycomparable
to DE and significantlesssideeffects.
917-73 Extent of Jeopardized Myocardium Correlates With
Heart Rate: A Dobutamine Stress
Echocardiographic Study
K. Ramani,J.A. Lsraen,J.V.Talano,F.A.Chaudhry.Nortfrwestem
University Chicago, IL, USA, Allegheny University of the Heafth Sciences,
Philadelphia, PA, USA
Correlationbetweenextent and severityof coronaryartery disease (CAD)
with heart rate (HR) and/or doubleproductwith dobutaminestress echo-
cardiogrsphy(DSE) is not well defined.Therefore, we evaluated 117 pta
(85 male, 32 female, age 84.5 + 1.1 yrs), who developednew reversible
segmentalwall motionabnormalities(WMA) duringDSE. All pta underwent
cardiaccatheterization(within6 monthsof DSE). Dobutaminewas infusedin
stepwiseincrementsat 10-50 @f@min. Studyendpointwas DSE detection
of WMA, at whichtimeths peak HR and doubleproductwere noted.All pta
CAD Age(yrs) No. M:F Debut PeakHR % PredHR DoubleProduct
NOD 63,5+2.1 19 11:6 27.1+3,2 134.2+2.6 84.2*2.4 21324*1O.4
lVD 64.1+2.2 30 20:10 29.6+2,5 126,S+2.6 84.2+2.4 20443+983
2VD 64.2*2.5 33 28:5 27.6+2.2 120.5+3.9 78.3k2.5 17420+666”
3VD 65.7+1.5 35 26:9 21.0+2.1a 109.9+3.9*b 71.4+2.5 15562+762*.b
‘p <0.001 vs.non-obstructivedisease;bp<0.001 vs.l-vesseldisease;ap<0,05 vs.
all3groups.(Debut=peakdobutaminedosainwglkg.?min)
